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Abstract: Adequate nutritional status may influence progression to frailty. The purpose of this
study is to determine the prevalence of frailty and examine the relationship between dietary protein
intake and the transition between frailty states and mortality in advanced age. We used data from
a longitudinal cohort study of Māori (80–90 years) and non-Māori (85 years). Dietary assessments
(24-h multiple pass dietary recalls) were completed at the second year of follow-up (wave 2 and
forms the baseline in this study). Frailty was defined using the Fried Frailty criteria. Multi-state
modelling examined the association of protein intake and transitions between frailty states and death
over four years. Over three quarters of participants were pre-frail or frail at baseline (62% and 16%,
respectively). Those who were frail had a higher co-morbidity (p < 0.05), where frailty state changed,
44% showed a worsening of frailty status (robust→ pre-frail or pre-frail→ frail). Those with higher
protein intake (g/kg body weight/day) were less likely to transition from robust to pre-frail [Hazard
Ratio (95% Confidence Interval): 0.28 (0.08–0.91)] but also from pre-frail to robust [0.24 (0.06–0.93)].
Increased protein intake was associated with lower risk of transitioning from pre-frailty to death
[0.19 (0.04–0.80)], and this association was moderated by energy intake [0.22 (0.03–1.71)]. Higher
protein intake in this sample of octogenarians was associated with both better and worse outcomes.
Keywords: frailty; mortality; protein deficiency; indigenous health; multi-state modelling
1. Introduction
Frailty is a multidimensional geriatric syndrome considered to be a state of increased
vulnerability to external stressors (acute illness, injury, or stress) [1]. The inability to recover
fully from these stressors is linked to adverse health outcomes over time, including an
increased risk of falls, cognitive impairment, functional decline, re-admission to hospital
and admission to residential age care [2]. Frailty can be defined using either a cumulative
deficit approach or a phenotypic approach [3,4]. The frailty phenotype is most commonly
determined by the presence of five physical characteristics: weakness, fatigue, slowness,
unintentional weight loss and low physical activity [2], whereas cumulative deficit ap-
proaches, such as the Frailty Index, consider the accumulation of health conditions and
impairments from physical, psychological and social domains [3,4]. Individuals in a pre-
frail or at-risk state (1–2 of these five characteristics) may or may not transition into overt
frailty (three or more of the five) [5].
The prevalence of frailty increases with age [6], which, combined with the current
worldwide growth in the number of older adults, will have an increasing impact on
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healthcare resources. Identifying factors that could form the basis of health interventions
to reduce frailty onset or progression is, therefore, of major public health importance.
Frailty often coexists with poor nutritional status [7] and is closely linked to one of the
frailty phenotypes, unintentional weight loss; but also has a potential mechanistic link to
weakness through loss of muscle mass
Dietary protein is required for muscle growth and repair. During digestion, protein
is broken down into amino acids, the building blocks for muscle tissue. In addition to
digestion, bioavailability of amino acids is also closely related to the absorption rates
of amino acids [8]. With ageing, there is a higher rate of muscle protein breakdown
and anabolic resistance which put older adults at increased risk muscle loss [8,9]. These
mechanisms provide some explanation of previous epidemiological findings that lower
dietary protein intakes are associated with poorer frailty status [10–14]. Few studies have
investigated the association between dietary protein and the progression of frailty status in
those aged 80 years and over, nor has the frailty status of older Māori people (indigenous
people of Aotearoa New Zealand) been previously examined. Māori people have a different
body composition with a higher ratio of lean mass to fat mass when compared to New
Zealand European [15], at least in younger age groups, and it is not known how this
difference in body composition is reflected in advanced age.
Thus, this study aimed to determine the prevalence of frailty in Māori and non-Māori
in advanced age and to examine the relationship between dietary protein intake and the
transition between frailty states and mortality in advanced age.
2. Materials and Methods
2.1. The Life and Living to Advanced Age Cohort Study in New Zealand (LiLACS NZ)
Te Puawaitanga O Nga Tapuwae Kia ora Tonu, Life and Living to Advanced Age: A
Cohort Study in New Zealand (LiLACS NZ) is a bicultural longitudinal study that aims to
determine the predictors of successful advanced ageing. Multiple sampling strategies were
used to contact eligible older adults, with the New Zealand (NZ) Māori Electoral Roll and
NZ General Electoral Roll as the primary source. Eligibility criteria included non-Māori
(mainly decedents from the United Kingdom) born in 1925 and Māori (the indigenous
people of Aotearoa New Zealand) born between 1920 and 1930 who were living within
defined regional boundaries in the central of the North Island. The wider age range for
Māori was because of low population numbers in the age group and the aim to recruit equal
size groups to allow meaningful analyses for Māori. Of the 1636 who were eligible, 937
octogenarians (57% response rate) were recruited at wave 1, of which nearly half (n = 421,
44%) were Māori. Details of the recruitment process have been described previously [16].
An annual comprehensive sociodemographic and health questionnaire was administered
by trained interviewers between 2010 (wave 1) and 2016 (wave 6). In 2011 (wave 2) 62%
(578/937) of the enrolled participants underwent detailed dietary assessment. Ethical
approval was provided by the Northern X Regional Ethics Committee (NXT 09/09/088) in
2009, and all participants provided written consent.
To be eligible for inclusion in this sub-study (secondary analysis) participants needed
to be living in the community at wave 2, and have complete frailty, body weight and
protein intake data.
2.2. Dietary Protein Intake
Two 24-h Multiple Pass Dietary Recalls (24 h MPR) were completed on two different
days by 62% of the original sample, 87% of wave 2 (216 Māori and 362 non-Māori) during
the 2011 (wave 2, n = 660) data collection. Nutrient intakes were calculated using the New
Zealand 2010 FOODfiles (Food Composition Database) [17]. Protein intake was expressed
as gram per kilogram of body weight per day (g/kg BW/d, continuous), per increase in
10 g/d increments (continuous), and as a binary variable using cut points of ≥0.8 g/kg
BW/d and ≥1.0 g/kg BW/d [9].
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2.3. Anthropometry Functional and Health Measures
Body weight, kilogram (kg) was measured using the Tanita Inner Scan Body Composi-
tion Monitor, BC-545 (Tanita Corporation, Tokyo, Japan). Height, metre (m) was measured
using a portable stadiometer, SECA 213 (SECA Corporation, Hamburg, Germany). For
participants who were unable to stand, height was estimated from demi-span, a mea-
sure closely related to height [18]. BMI was calculated as weight/height2 (kg/m2). Grip
strength was assessed using a Takei digital handgrip dynamometer-Grip D (Takei Scientific
Instruments, Niigata City, Japan), over three attempts in each hand while in a standing
position. The best performance by either hand was reported. Gait speed was assessed using
the timed three-metre walk according to the protocol in the Short Physical Performance
Battery [19] and expressed as metres per second (m/s). Physical activity level was assessed
with the validated Physical Activity Scale for the Elderly (PASE) [20]. The PASE represents
three domains of physical activities: recreational physical activities, housework related
activities and work-related activities. Each activity was weighted according to different
levels of intensity, and the score ranged from 0 to 793, with higher scores indicating greater
physical activity. Co-morbidity was ascertained from self-reported chronic medical condi-
tions and review of medical records from the general practices and hospital records from
the Ministry of Health. Nineteen conditions were ascertained: coronary artery disease,
cerebrovascular disease, congestive heart failure, peripheral vascular disease, hypertension,
asthma/chronic obstructive pulmonary disease, osteoporosis, osteoarthritis, rheumatoid
arthritis, diabetes, dementia, depression, cancer, thyroid disease, Parkinson disease, atrial
fibrillation, anemia, renal impairment, and eye disease. A condition was considered
present when reported in any of the data source(s). The total number of conditions was
summed [21].
2.4. Frailty States
A frailty score was derived from each wave of data collection using the five phe-
notypes of the Fried Criteria [2]. Participants were assigned a score of 0 (absence) or
1 (presence) for each of five items; unintentional weight loss (≥5% weight loss in the last
12 months), weakness (grip strength < 20 kg for women; <30 kg for men) [22], poor en-
durance/fatigue (a negative response to “Do you feel full of energy?”), slowness (defined
by gait speed < 0.8 m/s) [23], and low physical activity (sex-specific lowest quartile of the
total PASE score). If gait speed was unable to be measured, the slowness criteria were
imputed from an alternative question; “Do you walk around outside?” A negative response,
or where assistance was required, was defined as the presence of slowness. The absence of
all items scored 0 and was classified as robust, the presence of 1 or 2 items as pre-frail and
3–5 as frail [2].
Management of Missing Frailty Items
Where one or more frailty item was missing, participants could not be classified as
robust. Those with missing items and who moved to residential aged care facility after
wave 2, were classified as ‘frail’. In New Zealand, admission to residential age care facility
follows a thorough needs assessment for people with physical, intellectual and/or sensory
impairment or disability that reduces their ability to function independently over time.
Community-dwelling participants with missing frailty items had frailty scores imputed
based on the following criteria: one item missing and frailty score = 0–1, impute as ‘pre-
frail’; one item missing and frailty score ≥ 2, impute as ‘frail’; two items missing and frailty
score = 0, impute as ‘pre-frail’; and two or more items missing and frailty score ≥ 0, then
impute as ‘frail’. Frailty was considered a missing value if all five items were missing
(regardless of residence). This conservative imputation approach facilitates the retention of
cases to improve the stability of the statistical models.
Nutrients 2021, 13, 2843 4 of 12
2.5. Statistical Analysis
Data from wave 2 forms baseline data for this study with frailty state transitions
assessed between each wave, finishing with wave 6 of data collection. Descriptive statistics
were completed for all variables. Categorical variables are reported as frequency (per-
centage, %). Variables with a normal distribution are presented as means and standard
deviations (SD), while variables with a non-normal distribution are presented as medians
and interquartile ranges (IQR).
Association between frailty status in Māori (adjusted for age) and non-Māori at
baseline were assessed using ordinal regression model. Association between frailty status
and potential confounders listed in Table 1 were assessed with chi-square test (categorical
variables) or one-way ANOVA (continuous variables).
Table 1. Health and sociodemographic characteristics of 459 robust, pre-frail and frail LiLACS NZ







Score = 3–5 Total p *
n 102 (22%) 285 (62%) 72 (16%) 459
Women, n (%) 47 (46.1) 161 (56.5) 39 (54.2) 247 (53.8) 0.194
Age, (years) 85.1 (2.0) 85.4 (1.7) 85.7 (1.7) 85.4 (1.8) 0.067
Māori, n (%) 38 (37.3) 89 (31.2) 19 (26.4) 146 (31.8) 0.299
Education, n (%) 0.956
Primary or no schooling 17 (16.8) 62 (21.8) 19 (26.4) 98 (21.4)
Secondary school, no
qualification 37 (36.6) 101 (35.6) 23 (31.9) 161 (35.2)
Secondary school,
qualification 22 (21.8) 59 (20.8) 15 (20.8) 96 (21.0)
Trade, occupational 9 (8.9) 24 (8.5) 6 (8.3) 39 (8.5)
Tertiary qualification 16 (15.8) 38 (13.4) 9 (12.5) 63 (13.8
Co-morbidity 2.4 (2.0) 2.8 (1.7) 4.1 (2.4) 2.9 (2.0) <0.001
Body weight, (kg) 73.4 (11.1) 70.7 (13.1) 71.2 (16.3) 71.4 (13.3) 0.219
BMI, (kg/m2) 27.7 (4.0) 27.1 (4.3) 27.3 (6.4) 27.3 (4.7) 0.555
Energy intake, (MJ/d) 7.5 (2.4) 7.1 (2.2) 6.8 (2.4) 7.2 (2.3) 0.141
Protein intake, (g/d) 71.1 (24.1) 67.3 (21.9) 64.1 (25.7) 67.7 (23.1) 0.134
Men 80.8 (25.2) 74.5 (23.2) 75.6 (28.3) 76.3 (25.6) 0.288
Women 59.8 (17.0) 61.8 (19.1) 54.4 (18.7) 60.3 (18.8) 0.086
Protein intake,
(g/kg BW/d) 0.99 (0.37) 0.97 (0.31) 0.93 (0.38) 0.97 (0.34) 0.508
Men 1.08 (0.39) 0.97 (0.32) 1.02 (0.43) 1.01 (0.36) 0.177
Women 0.89 (0.32) 0.97 (0.31) 0.86 (0.32) 0.93 (0.31) 0.071
≥0.8 g/kg BW/d, n (%) 66 (64.7) 198 (69.5) 44 (61.1) 308 (67.1) 0.339
Men 42 (76.4) 89 (71.8) 24 (72.7) 155 (73.1) 0.814
Women 24 (51.1) 109 (67.7) 20 (51.3) 153 (61.9) 0.039
≥1.0 g/kg BW/d, n (%) 42 (41.2) 118 (41.4) 26 (36.1) 186 (40.5) 0.708
Men 28 (50.9) 49 (39.5) 15 (45.5) 92 (43.4) 0.353
Women 14 (29.8) 69 (42.9) 11 (28.2) 94 (38.1) 0.103
Carbohydrate intake,
(g/d) 194 (58.6) 187 (55.0) 178 (60.0) 187 (56.7) 0.203
Fat intake, (g/d) 75.5 (32.7) 71.4 (31.9) 69.7 (37.1) 72.1 (33.0) 0.455
Misreporters, n (%) 30 (29.4) 86 (30.2) 26 (36.1) 142 (30.9) 0.580
Entries are means ± SD unless mentioned. * Unadjusted non-difference between frailty states by chi-square test
(categorical variables) or one-way ANOVA (continuous variables). Estimated average requirement (EAR) and rec-
ommended dietary intakes (RDI) for adults > 70 years in Australia and New Zealand: Men: 65 g/day and 81 g/day.
Women: 46 g/day and 57 g/day [24]. The EAR and RDI for adults > 70 years in Australia and New Zealand:
Men: 0.86 g/kg BW/day and 1.07 g/kg BW/day. Women: 0.75 g/kg BW/day and 0.94 g/kg BW/day [25].
Co-morbidity (measured at wave 1) is the sum of 19 chronic diseases. All other variables were measured one year
later at wave 2 (considered baseline in this study). BMI, body mass index; BW, body weight; MJ, megajoules.
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To determine the association of protein intake to transitions between frailty states
and/or to death over four years, we fitted different multi-state models with increasing com-
plexity (Model 1–3) and with different exposures of interest (increase of 10 g of protein/day,
increase of 1 g of protein/kg of BW/day and ≥0.8 g/kg of BW/d). Model 1 is adjusted for
age, ethnicity, sex and protein intake (and weight in the case of protein not expressed by
body weight); Model 2 is further adjusted for co-morbidity; and Model 3 is further adjusted
for energy intake. Due to the limited number of transitions between non-adjacent states
(e.g., robust to frail) and the consequent non-convergence of the final models, we assumed
that transitions from robust to frail or vice versa had to go through pre-frail, and that death
from a robust state was not possible. Therefore, the allowed transitions were: Robust→
Pre-Frail, Pre-Frail→ Robust, Pre-Frail→ Frail, Frail→ Pre-Frail, Pre-Frail→ Dead, and
Frail→ Dead.
Multi-state models describe the movement of an individual between finite states in a
continuous time stochastic process under the Markov assumption that the next state is only
influenced by the current state [26,27]. Multi-state models were fitted with the msm package
in R v3.2.2 [28]. Point estimates and confidence intervals were used to assess statistical
and clinical significance. The Broyden-Fletcher-Goldfarb-Shanno algorithm (quasi-newton
optimization technique) was used to maximize the likelihood with results presented as
hazard ratios (HR) and 95% confidence intervals (CI).
As a sensitivity analysis, models were further adjusted for misreporters, or education
level (as categorized in Table 1), or using 1 g/kg BW/d or energy-adjusted protein intake
(residual method) as the exposure, adding an interaction between protein intake and
ethnicity. Models were fitted separately for Māori and non-Māori, or including participants
living in rest homes or not imputing slowness. Misreporters were defined as having a ratio
of energy intake: estimated basal metabolic rate below 1.05 and over 2.0 [25].
3. Results
Complete frailty data was available for 459 LiLACS NZ participants. One-third of
participants (31.8%) were Māori with a mean (SD) age of 84.1 (2.6) years and Non-Māori
86.1 (0.5) years. There was a higher proportion of females in both Māori and non-Māori
cohorts (57% and 53%, respectively). Participants without frailty scores at wave 2 differed
from those in the analysis sample with a higher BMI, lower carbohydrate intake, and a
greater proportion were Māori (Table S1).
At baseline (wave 2), frail octogenarians had a higher co-morbidity (frail participants
had 4.1 chronic diseases (SD:2.4), pre-frail 2.8 (SD:1.7) and robust 2.4 (SD:2.0) (p < 0.001))
(Table 1). While not statistically significant, frail participants tended to be older and
had lower energy and protein intakes than robust and pre-frail participants Table 1 and
Table S2).
Fewer than one quarter of participants (22%, 102/459) were classified as robust (Fried
score = 0) at baseline, with the majority (62%, 285/459) classified as pre-frail (Fried score = 1
or 2) (Figure 1). The percentage of participants classified as robust decreased yearly over
the four years follow-up (e.g., 22% at baseline to 14% at 48 months). Conversely, the
proportion classified as pre-frail was virtually stable (62% at baseline vs. 65% at 48 months).
A significantly higher proportion of men than women were robust at 12-month (p = 0.005),
24-month (p = 0.003), and 48-month (p = 0.011) independent of age and ethnicity. Frailty
did not differ between ethnic groups at any wave.


















68% 67% 69% 65%
64%
65%
16% 16% 16% 18% 17% 20% 22% 17% 27%
17% 15% 19% 22% 16% 26%
All Men Women All Men Women All Men Women All Men Women All Men Women
Baseline 12m 24m 36m 48m
A) Proportion of frailty states in each study wave by sex
Robust Pre-Frail Frail
Figure 1. Frailty states by sex (A) and ethnicity: Māori (B) non-Māori (C) for all five waves.
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In the Māori sample, the proportion of Māori men who were robust was relatively
stable over the follow-up duration except for a dip at 36 months; a higher proportion of
Māori women than men were frail (12 m p = 0.015; 24 m p = 0.006) (Figure 1b) In non-Māori
participants, the difference in frailty status between men and women was comparable
except at 24 and 48 months follow-up, a higher proportion women were frail compared to
men (27% vs. 17—19%), but this difference did not reach statistical significance (Figure 1C).
3.1. Number of Transitions and Baseline Characteristics by Frailty State and to Death
A total of 1269 “frailty state transitions” were examined over four years of frailty data
collection (Table 2). Of these, 692 remained unchanged in the same state from one wave to
another. A further, 28 transitions to non-adjacent states (robust→ frail, robust→ death
and recovery from frail→ robust) were not considered due to the low numbers of each
transition (Table 2). The total number of transitions used in the analytic sample, therefore,
was 549 where 44% were from robust→ pre-frail (124) or pre-frail→ frail (117) (Table 2).
These categories represent having at least one transition, and some participants had the
same transition twice (therefore it does not sum to 549). Further, each participant may have
had more than one different transition and, therefore, observations are not independent.
Table 2. Number of “transitions” between each frailty state and to death over four years.
To Robust Pre-Frail Frail Dead
From
Robust 95 124 4 20
Pre-frail 84 501 117 87
Frail 4 74 96 63
For example, 124 transitions were from robust to pre-frail. Notes: Font color red: worsening of frailty transitions;
grey: unchanged; green: improved; black: transitions between non-adjacent states (e.g., robust to frail). Robust,
Fried score = 0; Pre-frail, Fried score = 1–2; Frail= Fried score = 3–5.
The distribution of participant characteristics at baseline (wave 2) for all allowed
transitions are shown in Table S3. Fewer women recovered from pre-frail to robust and/or
transitioned from pre-frail to death. Moving from a pre-frail state to death was the most
common transition for Māori (39% vs. approximately 20% for robust to pre-frail (Table S3)).
Those who recovered from pre-frail to robust had lower disease burden and, in general,
higher nutritional intake (energy, protein, carbohydrate and fat).
3.2. Protein Intake and Transitions between Frailty States and to Death
We fitted different multi-state models with increasing complexity (Model 1–3) and
with different exposures of interest (increase of 10 g of protein/d, intake of 1 g/kg of BW/d
and ≥0.8 g/kg of BW/d) (Table 3). There were no statistically significant differences in the
likelihood of transition with lower or higher protein intake (≥0.8 g/kg BW/day) (Table 3
and Figure S1). Those with higher protein intake (per 1 g/kg of BW/d were less likely
to transition from robust to pre-frail (Model 3: g/kg BW/d: HR: 0.28, 95%CI: 0.08–0.91)
and pre-frail to dead (Model 2: g/kg BW/d: HR: 0.19, 95%CI: 0.04–0.80). Unexpectedly,
those with higher protein intake (g/kg BW/d) tended to also be less likely to recover from
pre-frail to robust (Model 3: g/kg BW/d: HR: 0.24, 95%CI: 0.06–0.93) (Table 3). Conclusions
did not differ in any of the sensitivity analyses.
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Table 3. Hazard ratios and 95% confidence intervals for the association between protein intake and transitions between
frailty states and to death over four years.
Increase of 10 g/day Increase of 1 g/kg BW/day ≥0.8 g/kg BW/day
HR 95% CI HR 95% CI HR 95% CI
Robust→ Pre-Frail (n = 124)
Model 1 0.95 0.85–1.06 0.49 0.25–0.96 0.74 0.47–1.17
Model 2 0.94 0.84–1.06 0.50 0.25–1.02 0.75 0.47–1.21
Model 3 0.85 0.69- 1.05 0.28 0.08–0.91 0.74 0.43–1.25
Pre-Frail→ Robust (n = 84)
Model 1 0.92 0.82–1.04 0.49 0.22–1.09 0.60 0.33–1.10
Model 2 0.92 0.81–1.03 0.47 0.21–1.05 0.61 0.33–1.13
Model 3 0.81 0.65–1.01 0.24 0.06–0.93 0.58 0.30–1.14
Pre-Frail→ Frail (n = 117)
Model 1 1.00 0.91–1.09 1.02 0.57–1.80 0.71 0.47–1.07
Model 2 1.00 0.91–1.11 1.19 0.66–2.15 0.72 0.46–1.13
Model 3 1.03 0.87–1.22 1.59 0.72–3.55 0.65 0.39–1.09
Frail→ Pre-Frail (n = 74)
Model 1 1.06 0.95–1.19 1.59 0.76–3.32 0.92 0.49–1.72
Model 2 1.06 0.94–1.19 1.63 0.76–3.52 0.77 0.39–1.55
Model 3 1.04 0.87–1.24 1.78 0.63–5.05 0.66 0.30–1.43
Pre-Frail→ Dead (n = 87)
Model 1 0.85 0.68–1.06 0.29 0.05–0.92 0.72 0.30–1.70
Model 2 0.85 0.68–1.06 0.19 0.04–0.80 0.63 0.27–1.47
Model 3 0.98 0.65–1.49 0.22 0.03–1.71 1.16 0.39–3.47
Frail→ Dead (n = 63)
Model 1 1.07 0.97–1.19 1.96 1.05–3.66 0.93 0.56–1.56
Model 2 1.07 0.96–1.19 2.01 1.09–3.73 0.99 0.59–1.67
Model 3 1.03 0.87–1.22 2.04 0.94–4.45 0.76 0.42–1.40
Model 1 is adjusted for age at wave 2, sex and ethnicity, (and weight in the case of protein not expressed by body weight). Model 2 is further
adjusted for co-morbidity and Model 3 is further adjusted for energy intake. BW, body weight; HR, hazard ratio; CI, confidence interval.
4. Discussion
There was a high prevalence of pre-frailty and frailty in New Zealand adults of
advanced age in LiLACS NZ. Frailty at baseline was not associated with protein intake but
was associated with a higher co-morbidity, and the proportion of participants classified as
frail increased as the cohort aged. The trends of frailty prevalence observed in LiLACS NZ
were similar to those seen in previous studies of community-dwelling people in advanced
age [29–32]. For instance, while fewer participants in LiLACS NZ were frail at baseline
compared to those in the Newcastle 85+ study, (16% vs. 24%, respectively) [29], prevalence
in frailty status were similar over time. Unlike the Newcastle 85+, we did not see any
significant differences between men and women in New Zealand. However, co-morbidity
was a characteristic of frail participants in both studies.
This is the first specific reporting of frailty status and transitions for Māori in advanced
age, to our knowledge. Māori participants had a lower prevalence of frailty at all waves
of the study, although this did not reach statistical significance. This tendency may reflect
the younger age of Māori participants and that they had a greater level of physical activity
at baseline [33]. It is notable, however, that Māori participants were more likely to have
chronic health conditions that may ultimately contribute to the development of frailty
including diabetes, respiratory conditions, and congestive heart failure [33].
In our sample, nearly one-fifth (19%) of the transitions between frailty states signified
a deterioration in frailty state (e.g., from robust to prefrail or pre-frail to frail) and more
than half (54%) of the transitions remained the same. Frailty transition states were not
unidimensionally related to protein intake. Of the three measures of protein intake, only
one measure was associated with frailty transition, i.e., the amount of protein intake by
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gram per kilogram (kg) body weight (BW) per day. Participants with higher protein intake
were less likely to transition from robust to pre-frail or pre-frail to death over four years in
models adjusted for key covariates. What is surprising was that participants with higher
protein intake (each gram increase in protein intake per kg of body weight) were less likely
to recover from pre-frail to robust. Our findings suggest a higher protein intake may halt
the deterioration of frailty status but perhaps not reverse the frailty trajectory. In addition to
the quantity of protein consumed, protein quality and distribution coupled with temporal
physical activity may reverse the frailty trajectory [9].
In cross-sectional studies, animal protein intake was found to have a positive dose-
response association with muscle mass in healthy older women (mean age 66 years old)
but not for plant protein [34]. However, the beneficial effect of animal protein was not
observed in frailty status, a measure of geriatric syndrome. In the Rotterdam Study (mean
age 75 years old), animal protein was not associated with risk of frailty. What is interesting
in the Rotterdam Study was an inverse association between plant protein and risk to be
frail, i.e., a higher plant protein was associated with a lower risk to be frail when compared
to the robust group [35]. In LiLACS NZ, the protein source varied between sex and ethnic
groups. Overall, there was a higher proportion of animal protein than plant protein (approx.
57% vs. 43%) [36], a proportion similar to the Rotterdam Study [35]. The impact of protein
source and distribution on transitions of frailty states was beyond the scope of this paper,
and further examination is warranted.
Our study also showed the association between protein intake and transitioning from
pre-frail or frail to dead was in an opposite direction. Higher protein intake was less
likely to transition from pre-frail to dead but more likely to transition from frail to dead.
These associations were, however, moderated by energy intake. Reverse causality between
energy intake in frail older adults may partly explain protein intake was not as strong in
this sample of octogenarians than in other studies. We note that the HR for the significant
transitions had a wide CI possibly due to the low number of transitions and/or distribution
of protein intake.
Protein intake was hypothesized to have an impact on frailty transition due to its role
in muscle anabolism. Cross-sectional studies have found that a higher protein intake was
inversely associated with frailty status in septuagenarian but not in octogenarians [11]. In
longitudinal studies, low protein intake was associated with increased odds of frailty in
sexagenarians but not in septuagenarians [11]. Protein intake in these observational studies
were expressed by various methods and different cut points: dichotomous groups (based
on recommended dietary protein intake cut points 0.8 g/kg BW/day), quintiles, tertiles, or
total daily protein intake. Our findings were in line with previous studies when protein
intake was expressed as high vs low (≥0.8 or ≥1.0 g/kg BW/day). The null association
between frailty status and protein intake (when expressed by as high vs. low) is potentially
associated with intrinsic factors, such as age-related changes in protein metabolism and
other factors including immunosenescence. Changes in the gastrointestinal tract alter
proteolysis, thereby affecting protein digestion and absorption [9,37]. Anabolic resistance
that has been noted in older adults also contributes to the imbalance between muscle
protein synthesis and muscle protein breakdown [9]. In view of these biological changes,
a higher protein intake may be required to halt the deterioration of frailty status. In our
sample, both men and women met the EAR for protein intake but not the RDI, although
the robust group come close to the recommendation. Achieving the current RDI may not
be sufficient to ward off lean muscle mass loss, particularly for those living to advanced
age. Progression to frailty occurs along a continuum, which provides opportunities for
targeted interventions to slow or halt the progression to full frailty [5].
We observed a significant association between the number of co-morbidities and
frailty, similar to that observed in previous work [29]. A recent meta-analysis of observa-
tional studies conducted with community-dwelling older adults found that multimorbidity
was associated with more than a two-fold increased likelihood of being frail (odds ra-
tio = 2.27; 95% CI = 1.97–2.62) [38]. Both the English Longitudinal Study of Ageing
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(aged ≥ 75 years) [39] and the Newcastle 85+ Cohort Study [29] also found that chronic
disease was positively associated with frailty progression. These findings emphasize the
complex interplay of multimorbidity and functional disability that contribute to frailty, as
examined by Pivetta et al. using path analysis [31].
Strengths and Limitations
This study included detailed dietary protein intake and annual measurement of frailty
status of octogenarians living in New Zealand and, to our knowledge, is the first paper to
report on the association between protein intake and frailty status in older Māori. Several
limitations are acknowledged. Dietary assessment (and protein intake) was only available
at wave 2 and, therefore, assumed to remain stable or to change proportionally in all
participants. Dietary intake is largely determined by our eating behavior which is quite
stable throughout the life-course. Probable factors impacting eating habits in this age group
include, but are not limited to, changes in living situation, health status, and medication
used [40]. We could not assign a frailty score for 139 (20%) participants at baseline, and it is
possible that those not included in the analytic sample were frailer than those who were.
We were not able to further adjust the various models for physical activity level in this
analysis as the activity level was included in the frailty score. Separate analysis of frailty
transitions was not possible for Māori participants due to the limited number of transition
states. However, this was addressed by adjusting for ethnicity in the model. Multi-state
modelling follows the Markov assumption that the next (frailty) state is only influenced
by the current state and, therefore, history of frailty status (prior to previous state) is not
considered. We recommend cautious interpretation of these findings in the context of the
study limitations and the wide confidence intervals for some exposures attributed to the
small sample size.
5. Conclusions
In this sample, nearly two-thirds of octogenarians were pre-frail and one-fifth were
robust. There was a higher proportion of older women than men who were frail over
four years. Octogenarians with higher protein intake were less likely to transition from
robust to pre-frail and pre-frail to dead. However, they were also less likely to recover from
pre-frail to robust. These findings suggest that the amount of protein intake alone was
insufficient to reverse the frailty trajectory but was able to prevent deterioration of frailty
states. Future studies integrating multiple approaches (quality and distribution of dietary
protein intake) with physical activity are warranted to maintain optimal function in older
adults transitioning to advanced age.
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to frailty status at baseline (wave 2); Table S3. Wave 2 characteristics by frailty state transition and
to death.
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